Expedited partner therapy is now legal in Washington, D.C., thanks to the passage of Bill 20-343. It’s a progressive step for a medical practice whose day is long overdue.
The Centers for Disease Control and Prevention has released sexually transmitted disease surveillance data for 2012, and the news is not good: Cases of chlamydia, gonorrhea, and syphilis all continued to rise.
A new website asks members to sign up for frequent STD testing and lets them share their results with other members confidentially. Encouraging STD testing is a good thing, but the site has major flaws. And when it comes to STDs, I can’t help but wonder if we would do best to leave the digital world in our pocket and just talk.
This week, a novel approach to infertility is announced, a new vaginal ring might be able to protect from HIV transmission, and the answer to preventing drug-resistant gonorrhea may be in our own immune systems.
A new report from the the Centers for Disease Control and Prevention warns of a post-antibiotic era in which none of the drugs we have work on gonorrhea and there are no new options.
A clinical trial found that two new combinations of existing drugs can cure gonorrhea, but is this enough to combat the possibility of an outbreak of antibiotic-resistant gonorrhea?
Antibiotic-resistant gonorrhea presents a looming public health crisis that could be prevented.
This week, Boston College gets support for its decision to halt student condom distribution, Nebraska tries to pass an expedited partner treatment law, and the bacon condom arrives just in time for April Fool’s Day (but it’s not a joke).
The CDC surveillance numbers for 2011 show that gonorrhea and chlamydia are up especially among young people and that three-quarters of all syphilis cases are among men who have sex with men; an analysis of STIs in New York City finds they are inextricably linked to poverty, and research suggests dormant HPV may reactivate as women near menopause.
The are over 700,000 cases of gonorrhea in the United States each year, and the bacteria itself has been changing and developing resistance to all but one class of antibiotics. With the likelihood that an antibiotic-resistant strain will be seen here soon, the CDC has released new treatment guidelines and a response a plan.